含 CD28 的 CD70靶向CAR-nk 细胞在体外和多种血液肿瘤和实体瘤模型中对 CD70+ 肿瘤细胞表现出了很高的细胞毒性。 结果显示，同时使用阿霉素和indisulam ...

Cytovia Therapeutics is uniquely positioned to deliver on the therapeutic promise through its plug-and-play cell therapy platform and complementary bispecific NK cell engagers. NK cells readily ...

I formulated the missing-self hypothesis for natural killer (NK) cell recognition in the autumn of 1981, while writing the last chapter of my doctoral thesis. In 1975, I had joined the Department ...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing on off ...

Biomissile Pharmaceuticals Co. Ltd. is developing multispecific antibodies that overcome resistance associated with antibody-drug conjugates via its next-generation natural killer (NK) cell engagers. ...

A number of signalling pathways have been identified as crucial in controlling NK cell metabolic and functional responses. Interestingly, the levels of nutrients and metabolites within the immune ...